Reference is made to the Memorandum of Understanding entered between BC Medicare Sdn. Bhd. (“BC Medicare”), a wholly-owned subsidiary of BCM and rLoop Limited (“rLoop”) (individually referred to as “Party” and collectively referred to as “Parties”) on 26 July 2021, the Board of Directors of BCM (“Board”) wishes to announce that BC Medicare had on 23 December 2021 entered into a Manufacturing Agreement (“the Agreement”) with rLoop and Euro-China Technology Achievement Transformation (Tianjin) Co. Ltd (“EC”) to provide manufacturing services for the virus attenuation devices using photon mediated electrons and emitters under rLoop’s own brand name of “rGuard – rLoop Virus Attenuation Device” (“Product”).

Please refer to the attachment for further information.

This announcement is dated 24 December 2021.